Skip to main content

RedHill Biopharma Ltd.

RDHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553846

In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in RedHill Biopharma Ltd. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
49
−8 vs. Q4 2021
Shares held
4.73M
−127.1K (−2.6%) vs. Q4 2021
Total value
$11.9M
−$618.1K (−4.9%) vs. Q4 2021
New holders
2
14 more added
Sold out
10
16 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RDHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 49 institutions
Q1 2021: 64 institutionsQ2 2021: 55 institutionsQ3 2021: 61 institutionsQ4 2021: 57 institutionsQ1 2022: 49 institutionsQ2 2022: 48 institutionsQ3 2022: 43 institutionsQ4 2022: 41 institutionsQ1 2023: 20 institutionsQ2 2023: 21 institutionsQ3 2023: 19 institutionsQ4 2023: 19 institutionsQ1 2024: 17 institutionsQ2 2024: 18 institutionsQ3 2024: 11 institutionsQ4 2024: 11 institutionsQ1 2025: 12 institutionsQ2 2025: 12 institutionsQ3 2025: 14 institutionsQ4 2025: 17 institutionsQ1 2026: 16 institutionsQ2 2026: 14 institutions
Value heldQ1 2022: $11.9M
Q1 2021: $77.4MQ2 2021: $49.1MQ3 2021: $24.5MQ4 2021: $12.5MQ1 2022: $11.9MQ2 2022: $3.89MQ3 2022: $1.46MQ4 2022: $1.51MQ1 2023: $1.20MQ2 2023: $419.2KQ3 2023: $781.9KQ4 2023: $449.2KQ1 2024: $1.40MQ2 2024: $719.7KQ3 2024: $48.8KQ4 2024: $103.5KQ1 2025: $80.5KQ2 2025: $37.9KQ3 2025: $51.2KQ4 2025: $514.5KQ1 2026: $386.5KQ2 2026: $270.0K
Institutions holding RDHL and their total value by quarter
QuarterHoldersValue
Q2 202614$270.0K
Q1 202616$386.5K
Q4 202517$514.5K
Q3 202514$51.2K
Q2 202512$37.9K
Q1 202512$80.5K
Q4 202411$103.5K
Q3 202411$48.8K
Q2 202418$719.7K
Q1 202417$1.40M
Q4 202319$449.2K
Q3 202319$781.9K
Q2 202321$419.2K
Q1 202320$1.20M
Q4 202241$1.51M
Q3 202243$1.46M
Q2 202248$3.89M
Q1 202249$11.9M
Q4 202157$12.5M
Q3 202161$24.5M
Q2 202155$49.1M
Q1 202164$77.4M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding RedHill Biopharma Ltd.; share changes are against Q4 2021.

Institutions holding RDHL in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Cutler Group LP200$00.00%−5,700−96.6%Reduced
Signaturefd, LLC100$00.00%00.0%Unchanged
Daiwa Securities Group Inc.70$00.00%00.0%Unchanged
Bedel Financial Consulting, Inc.66$00.00%00.0%Unchanged
Costello Asset Management, INC300$1.00K0.00%00.0%Unchanged
Wells Fargo & Company943$2.00K0.00%−1,693−64.2%Reduced
US Bancorp702$2.00K0.00%00.0%Unchanged
Citigroup Inc1,135$3.00K0.00%−293−20.5%Reduced
BDO Wealth Advisors, LLC1,000$3.00K0.00%00.0%Unchanged
Royal Bank of Canada1,600$4.00K0.00%−1,607−50.1%Reduced
IFP Advisors, Inc600$4.00K0.00%+300+100.0%Added
Bank of America Corp2,131$5.00K0.00%−345−13.9%Reduced
Atticus Wealth Management, LLC2,425$6.00K0.00%−2,000−45.2%Reduced
JPMorgan Chase & Co5,983$15.0K0.00%+1,434+31.5%Added
Tower Research Capital LLC (TRC)6,642$17.0K0.00%−2,399−26.5%Reduced
Steward Partners Investment Advisory, LLC7,500$19.0K0.00%00.0%Unchanged
Simplex Trading, LLC9,233$23.0K0.00%−39,118−80.9%Reduced
Commonwealth Equity Services, LLC12,237$30.0K0.00%+1,000+8.9%Added
D.A. Davidson & Co.16,800$42.0K0.00%00.0%Unchanged
Acadian Asset Management LLC16,780$42.0K0.00%+9,229+122.2%Added
Group One Trading, L.P.17,007$43.0K0.00%−11,988−41.3%Reduced
UBS Group AG17,484$44.0K0.00%−223,368−92.7%Reduced
Bank of New York Mellon Corp20,000$50.0K0.00%00.0%Unchanged
Two Sigma Securities, LLC25,499$64.0K0.01%+4,169+19.5%Added
Cambridge Investment Research Advisors, Inc.25,632$65.0K0.00%−2,000−7.2%Reduced
Mercer Global Advisors Inc26,559$67.0K0.00%00.0%Unchanged
Virtu Financial LLC26,864$68.0K0.01%+26,864New
Jane Street Group, LLC28,275$72.0K0.00%+1,999+7.6%Added
Goldman Sachs Group Inc36,958$93.0K0.00%−7,190−16.3%Reduced
Susquehanna International Group, LLP39,466$99.0K0.00%−11,604−22.7%Reduced
Morgan Stanley39,116$99.0K0.00%+3,596+10.1%Added
Eaton Vance Management40,417$102.0K0.00%+2,000+5.2%Added
Geode Capital Management, LLC41,637$104.0K0.00%+15,218+57.6%Added
National Bank of Canada43,000$108.0K0.00%00.0%Unchanged
Annandale Capital, LLC43,532$110.0K0.04%00.0%Unchanged
State Street Corp52,031$131.0K0.00%+2,991+6.1%Added
Citadel Advisors LLC57,713$145.0K0.00%−45,049−43.8%Reduced
Federation des caisses Desjardins du Quebec59,481$149.9K0.00%+3,298+5.9%Added
CIBC World Markets Inc.65,575$165.0K0.00%00.0%Unchanged
Creative Planning67,601$170.0K0.00%00.0%Unchanged
Candriam Luxembourg S.C.A.71,267$180.0K0.00%00.0%Unchanged
Barclays PLC76,500$193.0K0.00%00.0%Unchanged
Ancora Advisors, LLC82,048$207.0K0.01%−2,327−2.8%Reduced
Claret Asset Management Corp95,430$240.0K0.05%00.0%Unchanged
BlackRock Inc.357,493$901.0K0.00%+56,178+18.6%Added
Gagnon Securities LLC367,346$926.0K0.15%+49,023+15.4%Added
ARK Investment Management LLCSuperinvestorARK Invest861,798$2.17M0.01%+861,798New
Disciplined Growth Investors Inc1,950,002$4.91M0.11%+14,413+0.7%Added
Advisor Group Holdings, Inc.4,600––−4,800−51.1%Reduced
Proequities, Inc.0$00.00%−60−100.0%Sold out
Ibex Investors LLC0$00.00%−261,616−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−218,338−100.0%Sold out
Millennium Management LLC0$00.00%−175,058−100.0%Sold out
Alpine Global Management, LLC0$00.00%−64,558−100.0%Sold out
Parametric Portfolio Associates LLC0$00.00%−42,503−100.0%Sold out
Jump Financial, LLC0$00.00%−31,837−100.0%Sold out
HighTower Advisors, LLC0$00.00%−12,300−100.0%Sold out
Engineers Gate Manager LP0$00.00%−11,534−100.0%Sold out
Elmwood Wealth Management, Inc.0$00.00%−1,300−100.0%Sold out